Pharvaris (PHVS) EBT Margin (2023 - 2026)
Powered by 
Analysis
Pharvaris (PHVS) EBT Margin (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.43 Bn | 1,104.02 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 616.54 Bn | 535.06 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.55 Bn | 474.66 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 367.19 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.91 Bn | 261.90 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.40 Bn | 235.09 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 236.18 Bn | 191.58 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | -4.34% |
| 10 | Pharvaris | 1.83 Bn | 452.22 Mn | - | -2,385.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,385.32% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -3,783.72% |
| Mar 31, 2025 | -1,717.10% |
| Sep 30, 2024 | 0.00% |
| Sep 30, 2023 | -0.03% |
| Mar 31, 2023 | -1,620.20% |
API Access
Pharvaris EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();